Selank vs Semax

Selank combines a tuftsin-derived fragment with Pro-Gly-Pro; Semax combines ACTH(4-7) with Pro-Gly-Pro. The shared terminal sequence does not make the complete heptapeptides identical or establish a common exclusive target.

The cited mechanistic summaries also differ in what they measured. Selank work examined changes in labeled GABA binding in brain membranes, whereas Semax studies described BDNF and TrkB changes in rodents. A binding assay and a downstream molecular response are different kinds of evidence.

Selank: Selank is a synthetic heptapeptide formed by the tuftsin fragment extended with the stabilizing Pro-Gly-Pro sequence. In research models, it has been described as acting on neurotransmission pathways associated with monoaminergic systems and neurotrophic factor expression. It has been investigated in models of exploratory behavior in rodent studies.

Semax: Semax is a synthetic heptapeptide composed of the 4-7 fragment of corticotropin joined to the Pro-Gly-Pro sequence. In preclinical models, it has been described as acting on neurotrophic factor expression and central neurotransmission systems. It has been studied in models of neuronal plasticity in rodent studies.

Selank: In in vitro studies with brain membranes, Selank modified the binding of labeled GABA; the authors interpreted the findings as compatible with allosteric modulation. The assay does not establish an exclusive target for all its experimental responses.

Semax: Semax corresponds to the ACTH(4-7) fragment joined to Pro-Gly-Pro. Rodent studies observed changes in hippocampal BDNF and TrkB; these findings describe molecular responses and do not, by themselves, identify the peptide's binding site.

A dash means that the catalog does not declare that field for the compound. If neither entry declares a field, the row is omitted. A label purity specification of ≥ 99 % is not an analytical result; results must come from the certificate for the relevant batch.

Reconstitution: Laboratory procedure: allow the closed vial to reach room temperature, disinfect the septum and slowly transfer the diluent against the inner wall of the vial. Do not shake; gently swirl the vial until fully dissolved. Record the volume, diluent and date in the batch log.

Storage: Sealed vial of lyophilized material: store at −20 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles of reconstituted material; aliquot when the experimental design permits.

Protective equipment: Handle in a clean work area with a lab coat, nitrile gloves and eye protection. Dispose of vials, tips and sharps according to the laboratory waste procedure.

Reconstitution: Laboratory procedure: allow the closed vial to reach room temperature, disinfect the septum and slowly transfer the diluent against the inner wall of the vial. Do not shake; gently swirl the vial until fully dissolved. Record the volume, diluent and date in the batch log.

Storage: Sealed vial of lyophilized material: store at −20 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles of reconstituted material; aliquot when the experimental design permits.

Protective equipment: Handle in a clean work area with a lab coat, nitrile gloves and eye protection. Dispose of vials, tips and sharps according to the laboratory waste procedure.

Consult each product page for its current presentations, availability, batch documentation and price. This comparison does not freeze commercial information in the research text.

The compendium entries contain the extended definitions, research context and indexed bibliography for each compound. The comparison organizes declared information; it does not replace study-specific interpretation or batch identity evidence.